logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > 7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5H-1-benzazepin-5-one CAS 137982-91-3

7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5H-1-benzazepin-5-one CAS 137982-91-3

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 137982-91-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:
CAS NO::
137982-91-3
Appearance::
White To Off-white Solid
Molecular Formula::
C18H15ClN2O4
Molecular Weight::
358.77600
EINECS NO::
NA
MDL NO::
NA
CAS NO::
137982-91-3
Appearance::
White To Off-white Solid
Molecular Formula::
C18H15ClN2O4
Molecular Weight::
358.77600
EINECS NO::
NA
MDL NO::
NA
7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5H-1-benzazepin-5-one CAS 137982-91-3

Product Description:

Product Name: 7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5H-1-benzazepin-5-one CAS NO: 137982-91-3


Synonyms:

7-chloro-1-(2-methyl-4-nitrobenzoyl)-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine;

7-Chloro-1-(2-methyl-4-nitrobenzoyl)-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one;

1H-benzo[b]azepine;


Chemical & Physical Properties:

Appearance: White to off-white solid

Assay :≥99.00%

Density: 1.387

Boiling Point: 573.345℃ at 760 mmHg

Flash Point: 300.548℃

Vapor Pressure: 0.0±1.6 mmHg at 25℃

Index of Refraction: 1.635

Storage: Refrigerator, under inert atmosphere

Solubility: DMSO (Slightly), Methanol (Slightly)


Safety Information:

HS Code: 2933990090


7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5H-1-benzazepin-5-one is an intermediate in synthesizing Tolvaptan-d7 (T536652), a labelled Tolvaptan (T536650). It is a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.